SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001787306-23-000106
Filing Date
2023-09-15
Accepted
2023-09-15 16:09:52
Documents
14
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A arqt-20230630.htm   iXBRL 10-Q/A 52694
2 RULE 13A-14(A) CERTIFICATION CEO exhibit311ceoq22023-amendm.htm EX-31.1 10826
3 RULE 13A-14(A) CERTIFICATION CFO exhibit312cfoq22023-amendm.htm EX-31.2 10798
  Complete submission text file 0001787306-23-000106.txt   248141

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20230630.xsd EX-101.SCH 1901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20230630_lab.xml EX-101.LAB 32801
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20230630_pre.xml EX-101.PRE 17314
8 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20230630_htm.xml XML 4078
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39186 | Film No.: 231258820
SIC: 2834 Pharmaceutical Preparations